The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges

Lung cancer is one of the common malignant tumors that threaten human life with serious incidence and high mortality. According to the histopathological characteristics, lung cancer is mainly divided into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC accounts for about...

Full description

Bibliographic Details
Main Authors: Shimin Xie, Zhengguo Wu, Yi Qi, Binhua Wu, Xiao Zhu
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332221002353
id doaj-b4bc1cf224554eeab3f8b33be763c72f
record_format Article
spelling doaj-b4bc1cf224554eeab3f8b33be763c72f2021-05-20T07:45:03ZengElsevierBiomedicine & Pharmacotherapy0753-33222021-06-01138111450The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challengesShimin Xie0Zhengguo Wu1Yi Qi2Binhua Wu3Xiao Zhu4Guangdong Key Laboratory for Research and Development of Natural Drugs, The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, ChinaDepartment of Thoracic Surgery, Yantian District People's Hospital, Shenzhen, ChinaGuangdong Key Laboratory for Research and Development of Natural Drugs, The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China; Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang), Zhanjiang, ChinaGuangdong Key Laboratory for Research and Development of Natural Drugs, The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China; Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang), Zhanjiang, China; The Marine Biomedical Research Institute of Guangdong Zhanjiang, Zhanjiang, China; Corresponding author at: Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang), Zhanjiang, China.Guangdong Key Laboratory for Research and Development of Natural Drugs, The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China; Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang), Zhanjiang, China; The Marine Biomedical Research Institute of Guangdong Zhanjiang, Zhanjiang, China; The Key Lab of Zhanjiang for R&D Marine Microbial Resources in the Beibu Gulf Rim, Guangdong Medical University, Zhanjiang, China; Corresponding author at: Guangdong Key Laboratory for Research and Development of Natural Drugs, The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.Lung cancer is one of the common malignant tumors that threaten human life with serious incidence and high mortality. According to the histopathological characteristics, lung cancer is mainly divided into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC accounts for about 80–85% of lung cancers. In fact, lung cancer metastasis is a major cause of treatment failure in clinical patients. The underlying reason is that the mechanisms of lung cancer metastasis are still not fully understood. The metastasis of lung cancer cells is controlled by many factors, including the interaction of various components in the lung cancer microenvironment, epithelial-mesenchymal transition (EMT) transformation, and metastasis of cancer cells through blood vessels and lymphatics. The molecular relationships are even more intricate. Further study on the mechanisms of lung cancer metastasis and in search of effective therapeutic targets can bring more reference directions for clinical drug research and development. This paper focuses on the factors affecting lung cancer metastasis and connects with related molecular mechanisms of the lung cancer metastasis and mechanisms of lung cancer to specific organs, which mainly reviews the latest research progress of NSCLC metastasis. Besides, in this paper, experimental models of lung cancer and metastasis, mechanisms in SCLC transfer and the challenges about clinical management of lung cancer are also discussed. The review is intended to provide reference value for the future research in this field and promising treatment clues for clinical patients.http://www.sciencedirect.com/science/article/pii/S0753332221002353Lung cancerMetastasisTherapeutic challengesInfluencing factorsMolecular mechanisms
collection DOAJ
language English
format Article
sources DOAJ
author Shimin Xie
Zhengguo Wu
Yi Qi
Binhua Wu
Xiao Zhu
spellingShingle Shimin Xie
Zhengguo Wu
Yi Qi
Binhua Wu
Xiao Zhu
The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
Biomedicine & Pharmacotherapy
Lung cancer
Metastasis
Therapeutic challenges
Influencing factors
Molecular mechanisms
author_facet Shimin Xie
Zhengguo Wu
Yi Qi
Binhua Wu
Xiao Zhu
author_sort Shimin Xie
title The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
title_short The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
title_full The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
title_fullStr The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
title_full_unstemmed The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
title_sort metastasizing mechanisms of lung cancer: recent advances and therapeutic challenges
publisher Elsevier
series Biomedicine & Pharmacotherapy
issn 0753-3322
publishDate 2021-06-01
description Lung cancer is one of the common malignant tumors that threaten human life with serious incidence and high mortality. According to the histopathological characteristics, lung cancer is mainly divided into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC accounts for about 80–85% of lung cancers. In fact, lung cancer metastasis is a major cause of treatment failure in clinical patients. The underlying reason is that the mechanisms of lung cancer metastasis are still not fully understood. The metastasis of lung cancer cells is controlled by many factors, including the interaction of various components in the lung cancer microenvironment, epithelial-mesenchymal transition (EMT) transformation, and metastasis of cancer cells through blood vessels and lymphatics. The molecular relationships are even more intricate. Further study on the mechanisms of lung cancer metastasis and in search of effective therapeutic targets can bring more reference directions for clinical drug research and development. This paper focuses on the factors affecting lung cancer metastasis and connects with related molecular mechanisms of the lung cancer metastasis and mechanisms of lung cancer to specific organs, which mainly reviews the latest research progress of NSCLC metastasis. Besides, in this paper, experimental models of lung cancer and metastasis, mechanisms in SCLC transfer and the challenges about clinical management of lung cancer are also discussed. The review is intended to provide reference value for the future research in this field and promising treatment clues for clinical patients.
topic Lung cancer
Metastasis
Therapeutic challenges
Influencing factors
Molecular mechanisms
url http://www.sciencedirect.com/science/article/pii/S0753332221002353
work_keys_str_mv AT shiminxie themetastasizingmechanismsoflungcancerrecentadvancesandtherapeuticchallenges
AT zhengguowu themetastasizingmechanismsoflungcancerrecentadvancesandtherapeuticchallenges
AT yiqi themetastasizingmechanismsoflungcancerrecentadvancesandtherapeuticchallenges
AT binhuawu themetastasizingmechanismsoflungcancerrecentadvancesandtherapeuticchallenges
AT xiaozhu themetastasizingmechanismsoflungcancerrecentadvancesandtherapeuticchallenges
AT shiminxie metastasizingmechanismsoflungcancerrecentadvancesandtherapeuticchallenges
AT zhengguowu metastasizingmechanismsoflungcancerrecentadvancesandtherapeuticchallenges
AT yiqi metastasizingmechanismsoflungcancerrecentadvancesandtherapeuticchallenges
AT binhuawu metastasizingmechanismsoflungcancerrecentadvancesandtherapeuticchallenges
AT xiaozhu metastasizingmechanismsoflungcancerrecentadvancesandtherapeuticchallenges
_version_ 1721434805968568320